Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana

Table 4 Hypertension care cascade

	Baseline (n = 290)	12 months (n = 255)^a	95% CI^c	p-values
Aware of diagnosis	268 (92.4%)	n/a
On Treatment	242 (83.4%)	231 (79.7%)	-10.4, 2.86	0.284
Controlled BP	137 (47.2%)	206 (71.0%)	15.7, 31.9	< 0.001
Taking HTN Medications and Controlled BP^b	133 (55.0%)	189 (81.8%)	11.0, 27.6	< 0.001

^aThe 12 month follow-up proportions are based on n = 290 using the Intent to Treat analysis
^bThe proportions are based on the total number of participants on HTN medications
^c95% CI of the Difference at 12 months vs baseline

ISSN: 2662-2211